English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

Bimodal intracellular contrast agent based on the sugar moiety targeting beta-galactosidase

MPS-Authors
/persons/resource/persons83836

Brud,  AJ
Former Department MRZ, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84085

Mishra,  R
Former Department MRZ, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons83903

Engelmann,  J
Former Department MRZ, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Brud, A., Mishra, R., Ugurbil, K., Ziegler, T., & Engelmann, J. (2009). Bimodal intracellular contrast agent based on the sugar moiety targeting beta-galactosidase. Poster presented at Annual Workshop COST Chemistry D38: Metal-Based Systems for Molecular Imaging Applications, Warsaw, Poland.


Cite as: http://hdl.handle.net/21.11116/0000-0002-B427-7
Abstract
Molecular-genetic imaging is a rapidly growing field aimed at providing vital information about the distribution and level of gene expression in the living specimens over time. The common approaches to evaluate the efficiency of genetic manipulation in vivo usually involve the visualization of products formed by the expression of a reporter gene introduced together with the therapeutic gene of interest. Such reporter genes encode proteins, cell surface receptors or enzymes, which can be detected directly (fluorescent proteins (e.g. GFP)) or via interactions with compatible imaging probes. Although MRI has proved its excellent diagnostic capability as a routinely used tool in clinical practice, still a diminutive progress has been made in development of MR reporter genes and corresponding contrast agents [1]. Thus, highly specific and sensitive probes are required in order to achieve noninvasive imaging of gene expression in vivo by the means of MR imaging. The intracellular localization of many molecular targets inspired us to design a contrast agent which should accumulate inside the targeted cell by a specific interaction with a cytoplasmic constituent. Our model probe is based on a sugar moiety serving as enzymatically cleavable linker between transport part and MR probe targeting the intracellular enzyme beta-galactosidase. This enzyme is expressed by bacterial LacZ gene, a frequently used reporter gene. Bimodal contrast agents containing gadolinium chelator DOTA and fluorescent part (FITC) for combined MR/optical imaging were synthesized. The cellular uptake and subcellular localization of the obtained probe were evaluated by fluorescence spectroscopy and microscopy in a transgenic rat glioma cell line C6/LacZ (containing target: β-galactosidase) and compared with the parent C6 cells (without target). The cell studies showed that synthesized CA could enter efficiently into the cells in a concentration dependent manner from 5 to 20 μM without inducing significant toxicity. Concentration and time dependency of uptake were investigated. The ability of synthesized CA agents to increase intracellular relaxation rates of water protons was confirmed by in vitro MR cell studies. MR images of labeled cells showed significant contrast enhancement as compared to control cells.